Disambiguation evidence for mosunetuzumab (bispecific antibody component) via surface form
"mosunetuzumab (bispecific antibody component)"
Triples (1)
Triples where some other subject referred to this entity
as "mosunetuzumab (bispecific antibody component)".
CD20 protein
→
targetOf
→
"mosunetuzumab (bispecific antibody component)"
ⓘ
↳ resolves to mosunetuzumab (bispecific antibody component)